img

Global Menopausal Hormone Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Menopausal Hormone Therapy Market Insights, Forecast to 2034

Menopausal hormone therapy (MHT) is a treatment that uses hormones to relieve the symptoms of menopause. Menopause is a natural process that occurs when a woman's ovaries stop producing estrogen and progesterone. This can cause a variety of symptoms, including hot flashes, night sweats, vaginal dryness, mood swings, and difficulty sleeping.
Market Analysis and InsightsGlobal Menopausal Hormone Therapy Market
Global Menopausal Hormone Therapy market is expected to reach to US$ 25100 million in 2023, with a positive growth of %, compared with US$ 23500 million in 2022. Backed with the increasing demand from downstream industries, Menopausal Hormone Therapy industry is evaluated to reach US$ 35810 million in 2033. The CAGR will be 6.1% during 2023 to 2033.
The menopausal hormone therapy (MHT) market is expected to grow significantly in the coming years, driven by a number of factors, including
Rising awareness of the benefits of menopausal hormone therapyThere is a growing awareness of the benefits of menopausal hormone therapy, such as relief of menopausal symptoms, reduced risk of osteoporosis, and improved cardiovascular health. This is also driving the demand for menopausal hormone therapy.
Changing social normsSocial norms are changing around menopause, and women are becoming more open to discussing their symptoms and seeking treatment. This is also driving the demand for menopausal hormone therapy.
The North American region is expected to be the largest market for menopausal hormone therapy, followed by Europe and the Asia Pacific region. The growth of the market in the North American region is being driven by the high prevalence of menopause and the easy availability of menopausal hormone therapy products.
Overall, the menopausal hormone therapy market is expected to grow significantly in the coming years, driven by increasing population of menopausal women, rising awareness of the benefits of menopausal hormone therapy, and changing social norms.
Report Covers
This report presents an overview of global Menopausal Hormone Therapy market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Menopausal Hormone Therapy market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
Segment by Type
Estrogen
Progesterone

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Menopausal Hormone Therapy introduction, etc. Menopausal Hormone Therapy Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Menopausal Hormone Therapy
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Menopausal Hormone Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Estrogen
1.2.3 Progesterone
1.3 Market by Application
1.3.1 Global Menopausal Hormone Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Menopausal Hormone Therapy Market Perspective (2018-2033)
2.2 Global Menopausal Hormone Therapy Growth Trends by Region
2.2.1 Menopausal Hormone Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Menopausal Hormone Therapy Historic Market Size by Region (2018-2023)
2.2.3 Menopausal Hormone Therapy Forecasted Market Size by Region (2024-2033)
2.3 Menopausal Hormone Therapy Market Dynamics
2.3.1 Menopausal Hormone Therapy Industry Trends
2.3.2 Menopausal Hormone Therapy Market Drivers
2.3.3 Menopausal Hormone Therapy Market Challenges
2.3.4 Menopausal Hormone Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Menopausal Hormone Therapy by Players
3.1.1 Global Menopausal Hormone Therapy Revenue by Players (2018-2023)
3.1.2 Global Menopausal Hormone Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Menopausal Hormone Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Menopausal Hormone Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Menopausal Hormone Therapy Market Concentration Ratio
3.4.1 Global Menopausal Hormone Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Menopausal Hormone Therapy Revenue in 2022
3.5 Global Key Players of Menopausal Hormone Therapy Head office and Area Served
3.6 Global Key Players of Menopausal Hormone Therapy, Product and Application
3.7 Global Key Players of Menopausal Hormone Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Menopausal Hormone Therapy Breakdown Data by Type
4.1 Global Menopausal Hormone Therapy Historic Market Size by Type (2018-2023)
4.2 Global Menopausal Hormone Therapy Forecasted Market Size by Type (2024-2033)
5 Menopausal Hormone Therapy Breakdown Data by Application
5.1 Global Menopausal Hormone Therapy Historic Market Size by Application (2018-2023)
5.2 Global Menopausal Hormone Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Menopausal Hormone Therapy Market Size (2018-2033)
6.2 North America Menopausal Hormone Therapy Market Size by Type
6.2.1 North America Menopausal Hormone Therapy Market Size by Type (2018-2023)
6.2.2 North America Menopausal Hormone Therapy Market Size by Type (2024-2033)
6.2.3 North America Menopausal Hormone Therapy Market Share by Type (2018-2033)
6.3 North America Menopausal Hormone Therapy Market Size by Application
6.3.1 North America Menopausal Hormone Therapy Market Size by Application (2018-2023)
6.3.2 North America Menopausal Hormone Therapy Market Size by Application (2024-2033)
6.3.3 North America Menopausal Hormone Therapy Market Share by Application (2018-2033)
6.4 North America Menopausal Hormone Therapy Market Size by Country
6.4.1 North America Menopausal Hormone Therapy Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Menopausal Hormone Therapy Market Size by Country (2018-2023)
6.4.3 North America Menopausal Hormone Therapy Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Menopausal Hormone Therapy Market Size (2018-2033)
7.2 Europe Menopausal Hormone Therapy Market Size by Type
7.2.1 Europe Menopausal Hormone Therapy Market Size by Type (2018-2023)
7.2.2 Europe Menopausal Hormone Therapy Market Size by Type (2024-2033)
7.2.3 Europe Menopausal Hormone Therapy Market Share by Type (2018-2033)
7.3 Europe Menopausal Hormone Therapy Market Size by Application
7.3.1 Europe Menopausal Hormone Therapy Market Size by Application (2018-2023)
7.3.2 Europe Menopausal Hormone Therapy Market Size by Application (2024-2033)
7.3.3 Europe Menopausal Hormone Therapy Market Share by Application (2018-2033)
7.4 Europe Menopausal Hormone Therapy Market Size by Country
7.4.1 Europe Menopausal Hormone Therapy Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Menopausal Hormone Therapy Market Size by Country (2018-2023)
7.4.3 Europe Menopausal Hormone Therapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Menopausal Hormone Therapy Market Size (2018-2033)
8.2 China Menopausal Hormone Therapy Market Size by Type
8.2.1 China Menopausal Hormone Therapy Market Size by Type (2018-2023)
8.2.2 China Menopausal Hormone Therapy Market Size by Type (2024-2033)
8.2.3 China Menopausal Hormone Therapy Market Share by Type (2018-2033)
8.3 China Menopausal Hormone Therapy Market Size by Application
8.3.1 China Menopausal Hormone Therapy Market Size by Application (2018-2023)
8.3.2 China Menopausal Hormone Therapy Market Size by Application (2024-2033)
8.3.3 China Menopausal Hormone Therapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Menopausal Hormone Therapy Market Size (2018-2033)
9.2 Asia Menopausal Hormone Therapy Market Size by Type
9.2.1 Asia Menopausal Hormone Therapy Market Size by Type (2018-2023)
9.2.2 Asia Menopausal Hormone Therapy Market Size by Type (2024-2033)
9.2.3 Asia Menopausal Hormone Therapy Market Share by Type (2018-2033)
9.3 Asia Menopausal Hormone Therapy Market Size by Application
9.3.1 Asia Menopausal Hormone Therapy Market Size by Application (2018-2023)
9.3.2 Asia Menopausal Hormone Therapy Market Size by Application (2024-2033)
9.3.3 Asia Menopausal Hormone Therapy Market Share by Application (2018-2033)
9.4 Asia Menopausal Hormone Therapy Market Size by Region
9.4.1 Asia Menopausal Hormone Therapy Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Menopausal Hormone Therapy Market Size by Region (2018-2023)
9.4.3 Asia Menopausal Hormone Therapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Menopausal Hormone Therapy Introduction
11.1.4 Eli Lilly Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.1.5 Eli Lilly Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Menopausal Hormone Therapy Introduction
11.2.4 Pfizer Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.2.5 Pfizer Recent Developments
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Menopausal Hormone Therapy Introduction
11.3.4 AbbVie Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.3.5 AbbVie Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Menopausal Hormone Therapy Introduction
11.4.4 Novo Nordisk Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.4.5 Novo Nordisk Recent Developments
11.5 Merck KGaA
11.5.1 Merck KGaA Company Details
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Menopausal Hormone Therapy Introduction
11.5.4 Merck KGaA Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.5.5 Merck KGaA Recent Developments
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Menopausal Hormone Therapy Introduction
11.6.4 Mylan Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.6.5 Mylan Recent Developments
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Menopausal Hormone Therapy Introduction
11.7.4 Bayer Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.7.5 Bayer Recent Developments
11.8 Teva
11.8.1 Teva Company Details
11.8.2 Teva Business Overview
11.8.3 Teva Menopausal Hormone Therapy Introduction
11.8.4 Teva Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.8.5 Teva Recent Developments
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Menopausal Hormone Therapy Introduction
11.9.4 Novartis Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.9.5 Novartis Recent Developments
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Menopausal Hormone Therapy Introduction
11.10.4 Abbott Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.10.5 Abbott Recent Developments
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Menopausal Hormone Therapy Introduction
11.11.4 Roche Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.11.5 Roche Recent Developments
11.12 Endo International
11.12.1 Endo International Company Details
11.12.2 Endo International Business Overview
11.12.3 Endo International Menopausal Hormone Therapy Introduction
11.12.4 Endo International Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.12.5 Endo International Recent Developments
11.13 Ipsen
11.13.1 Ipsen Company Details
11.13.2 Ipsen Business Overview
11.13.3 Ipsen Menopausal Hormone Therapy Introduction
11.13.4 Ipsen Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.13.5 Ipsen Recent Developments
11.14 ANI Pharmaceuticals
11.14.1 ANI Pharmaceuticals Company Details
11.14.2 ANI Pharmaceuticals Business Overview
11.14.3 ANI Pharmaceuticals Menopausal Hormone Therapy Introduction
11.14.4 ANI Pharmaceuticals Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.14.5 ANI Pharmaceuticals Recent Developments
11.15 TherapeuticsMD
11.15.1 TherapeuticsMD Company Details
11.15.2 TherapeuticsMD Business Overview
11.15.3 TherapeuticsMD Menopausal Hormone Therapy Introduction
11.15.4 TherapeuticsMD Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.15.5 TherapeuticsMD Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Menopausal Hormone Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Estrogen
Table 3. Key Players of Progesterone
Table 4. Global Menopausal Hormone Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Menopausal Hormone Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Menopausal Hormone Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Menopausal Hormone Therapy Market Share by Region (2018-2023)
Table 8. Global Menopausal Hormone Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Menopausal Hormone Therapy Market Share by Region (2024-2033)
Table 10. Menopausal Hormone Therapy Market Trends
Table 11. Menopausal Hormone Therapy Market Drivers
Table 12. Menopausal Hormone Therapy Market Challenges
Table 13. Menopausal Hormone Therapy Market Restraints
Table 14. Global Menopausal Hormone Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Menopausal Hormone Therapy Revenue Share by Players (2018-2023)
Table 16. Global Top Menopausal Hormone Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopausal Hormone Therapy as of 2022)
Table 17. Global Menopausal Hormone Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Menopausal Hormone Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Menopausal Hormone Therapy, Headquarters and Area Served
Table 20. Global Key Players of Menopausal Hormone Therapy, Product and Application
Table 21. Global Key Players of Menopausal Hormone Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Menopausal Hormone Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Menopausal Hormone Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Menopausal Hormone Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Menopausal Hormone Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global Menopausal Hormone Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Menopausal Hormone Therapy Revenue Share by Application (2018-2023)
Table 29. Global Menopausal Hormone Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Menopausal Hormone Therapy Revenue Share by Application (2024-2033)
Table 31. North America Menopausal Hormone Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Menopausal Hormone Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Menopausal Hormone Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Menopausal Hormone Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Menopausal Hormone Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Menopausal Hormone Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Menopausal Hormone Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Menopausal Hormone Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Menopausal Hormone Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Menopausal Hormone Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Menopausal Hormone Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Menopausal Hormone Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Menopausal Hormone Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Menopausal Hormone Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Menopausal Hormone Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Menopausal Hormone Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Menopausal Hormone Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Menopausal Hormone Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Menopausal Hormone Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Menopausal Hormone Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Menopausal Hormone Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Menopausal Hormone Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Menopausal Hormone Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Menopausal Hormone Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Menopausal Hormone Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Menopausal Hormone Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Menopausal Hormone Therapy Product
Table 66. Eli Lilly Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 67. Eli Lilly Recent Developments
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Menopausal Hormone Therapy Product
Table 71. Pfizer Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 72. Pfizer Recent Developments
Table 73. AbbVie Company Details
Table 74. AbbVie Business Overview
Table 75. AbbVie Menopausal Hormone Therapy Product
Table 76. AbbVie Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 77. AbbVie Recent Developments
Table 78. Novo Nordisk Company Details
Table 79. Novo Nordisk Business Overview
Table 80. Novo Nordisk Menopausal Hormone Therapy Product
Table 81. Novo Nordisk Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 82. Novo Nordisk Recent Developments
Table 83. Merck KGaA Company Details
Table 84. Merck KGaA Business Overview
Table 85. Merck KGaA Menopausal Hormone Therapy Product
Table 86. Merck KGaA Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 87. Merck KGaA Recent Developments
Table 88. Mylan Company Details
Table 89. Mylan Business Overview
Table 90. Mylan Menopausal Hormone Therapy Product
Table 91. Mylan Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 92. Mylan Recent Developments
Table 93. Bayer Company Details
Table 94. Bayer Business Overview
Table 95. Bayer Menopausal Hormone Therapy Product
Table 96. Bayer Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 97. Bayer Recent Developments
Table 98. Teva Company Details
Table 99. Teva Business Overview
Table 100. Teva Menopausal Hormone Therapy Product
Table 101. Teva Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 102. Teva Recent Developments
Table 103. Novartis Company Details
Table 104. Novartis Business Overview
Table 105. Novartis Menopausal Hormone Therapy Product
Table 106. Novartis Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 107. Novartis Recent Developments
Table 108. Abbott Company Details
Table 109. Abbott Business Overview
Table 110. Abbott Menopausal Hormone Therapy Product
Table 111. Abbott Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 112. Abbott Recent Developments
Table 113. Roche Company Details
Table 114. Roche Business Overview
Table 115. Roche Menopausal Hormone Therapy Product
Table 116. Roche Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 117. Roche Recent Developments
Table 118. Endo International Company Details
Table 119. Endo International Business Overview
Table 120. Endo International Menopausal Hormone Therapy Product
Table 121. Endo International Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 122. Endo International Recent Developments
Table 123. Ipsen Company Details
Table 124. Ipsen Business Overview
Table 125. Ipsen Menopausal Hormone Therapy Product
Table 126. Ipsen Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 127. Ipsen Recent Developments
Table 128. ANI Pharmaceuticals Company Details
Table 129. ANI Pharmaceuticals Business Overview
Table 130. ANI Pharmaceuticals Menopausal Hormone Therapy Product
Table 131. ANI Pharmaceuticals Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 132. ANI Pharmaceuticals Recent Developments
Table 133. TherapeuticsMD Company Details
Table 134. TherapeuticsMD Business Overview
Table 135. TherapeuticsMD Menopausal Hormone Therapy Product
Table 136. TherapeuticsMD Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 137. TherapeuticsMD Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Menopausal Hormone Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Menopausal Hormone Therapy Market Share by Type: 2022 VS 2033
Figure 3. Estrogen Features
Figure 4. Progesterone Features
Figure 5. Global Menopausal Hormone Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Menopausal Hormone Therapy Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Menopausal Hormone Therapy Report Years Considered
Figure 11. Global Menopausal Hormone Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Menopausal Hormone Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Menopausal Hormone Therapy Market Share by Region: 2022 VS 2033
Figure 14. Global Menopausal Hormone Therapy Market Share by Players in 2022
Figure 15. Global Top Menopausal Hormone Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopausal Hormone Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Menopausal Hormone Therapy Revenue in 2022
Figure 17. North America Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Menopausal Hormone Therapy Market Share by Type (2018-2033)
Figure 19. North America Menopausal Hormone Therapy Market Share by Application (2018-2033)
Figure 20. North America Menopausal Hormone Therapy Market Share by Country (2018-2033)
Figure 21. United States Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Menopausal Hormone Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Menopausal Hormone Therapy Market Share by Type (2018-2033)
Figure 25. Europe Menopausal Hormone Therapy Market Share by Application (2018-2033)
Figure 26. Europe Menopausal Hormone Therapy Market Share by Country (2018-2033)
Figure 27. Germany Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Menopausal Hormone Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Menopausal Hormone Therapy Market Share by Type (2018-2033)
Figure 35. China Menopausal Hormone Therapy Market Share by Application (2018-2033)
Figure 36. Asia Menopausal Hormone Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Menopausal Hormone Therapy Market Share by Type (2018-2033)
Figure 38. Asia Menopausal Hormone Therapy Market Share by Application (2018-2033)
Figure 39. Asia Menopausal Hormone Therapy Market Share by Region (2018-2033)
Figure 40. Japan Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Menopausal Hormone Therapy Market Share by Country (2018-2033)
Figure 50. Brazil Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Eli Lilly Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 57. Pfizer Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 58. AbbVie Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 59. Novo Nordisk Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 60. Merck KGaA Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 61. Mylan Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 62. Bayer Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 63. Teva Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 64. Novartis Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 65. Abbott Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 66. Roche Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 67. Endo International Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 68. Ipsen Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 69. ANI Pharmaceuticals Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 70. TherapeuticsMD Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries